🇺🇸 Hyperbolic tapering in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Burning Sensation — 1 report (10%)
2. Delusion — 1 report (10%)
3. Hyperacusis — 1 report (10%)
4. Hypersexuality — 1 report (10%)
5. Hypoaesthesia — 1 report (10%)
6. Impulsive Behaviour — 1 report (10%)
7. Loss Of Personal Independence In Daily Activities — 1 report (10%)
8. Mania — 1 report (10%)
9. Neuropathy Peripheral — 1 report (10%)
10. Paraesthesia — 1 report (10%)

Source database →

Frequently asked questions

Is Hyperbolic tapering approved in United States?

Hyperbolic tapering does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Hyperbolic tapering in United States?

Universita di Verona is the originator. The local marketing authorisation holder may differ — check the official source linked above.